Cytokinetics reports third quarter 2014 financial results
Cytokinetics reported the net loss for the 2014 third quarter was $6.0 million, or $0.16 per basic and diluted share versus a net loss for the same period in 2013, of $12.6 million, or $0.43 per basic and diluted share. October 30, 2014